Artelo Biosciences Inc.
News
Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Globe Newswire SOLANA BEACH, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...\n more…
Artelo Biosciences, Inc. (NASDAQ:ARTL) Sees Significant Decrease in Short Interest
Ticker Report Artelo Biosciences, Inc. (NASDAQ:ARTL - Get Free Report) was the target of a significant decrease in short interest in August. As of August 15th, there was short interest totalling 37,300 shares, a...\n more…
HC Wainwright Weighs in on Artelo Biosciences, Inc.'s Q3 2024 Earnings (NASDAQ:ARTL)
Ticker Report Artelo Biosciences, Inc. (NASDAQ:ARTL - Free Report) - Research analysts at HC Wainwright boosted their Q3 2024 earnings per share estimates for Artelo Biosciences in a research note issued to...\n more…
HC Wainwright Reiterates "Buy" Rating for Artelo Biosciences (NASDAQ:ARTL)
Ticker Report Artelo Biosciences (NASDAQ:ARTL - Get Free Report)s stock had its "buy" rating reissued by analysts at HC Wainwright in a research note issued on Wednesday, Benzinga reports. They presently...\n more…
Artelo Biosciences (NASDAQ:ARTL) Announces Earnings Results
Ticker Report Artelo Biosciences (NASDAQ:ARTL - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.75) earnings per share for the quarter, topping analysts' consensus...\n more…
ARTL Stock Earnings: Artelo Biosciences Beats EPS for Q2 2024
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nARTL stock results show that Artelo Biosciences beat analyst estimates for earnings per share the second quarter of 2024.\nThe post ARTL...\n more…